Hereditary hemochromatosis is a common inherited disorder characterized by iron overload. A single mutation (C282Y) in the HFE gene is present in 80-95% of cases in populations of northern European extraction. The disorder presents a large phenotypic heterogeneity, and its expression can be influenced by environmental factors. This 1977-2002 study aimed to identify the influence of alcohol consumption on expression of the disease. The authors retrospectively registered 378 C282Y-homozygous patients treated in a blood center of western Brittany, France. In this cohort, 33 patients reported excessive alcohol consumption (8.7%). Those subjects presented significantly increased iron parameters (serum ferritin: 1,745.2 vs. 968.7 µg/liter, p< 0.0001; serum iron: 39.9 vs. 36.0 µmol/liter, p = 0.0040; transferrin saturation: 87.1 vs. 80.1%, p = 0.0071) and elevated liver enzymes (alanine aminotransferase: 66.3 vs. 41.1 IU/liter, p = 0.0003; aspartate aminotransferase: 56.2 vs. 34.9 IU/liter, p = 0.0002). Their risk of skin pigmentation was also higher (odds ratio = 3.4, p = 0.0006). Results remained unchanged after adjustment. This study provides precise quantitative data about the impact of alcohol on expression of hereditary hemochromatosis in C282Y-homozygous patients. Excessive alcohol consumption accentuates disease expression and therefore the risk of cirrhosis and cancer. Consequently, these patients should be encouraged to consume very moderate quantities of alcohol. alcohol drinking; disease susceptibility; hemochromatosis; hereditary diseases; iron overload Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval; OR, odds ratio.
Hereditary hemochromatosis is a common genetic disease of autosomal recessive inheritance that occurs predominantly in populations of northern and western European descent (prevalence: 1-4/1,000). It is characterized by excessive digestive absorption of iron, leading to its progressive accumulation in different tissues of the body (notably liver, pancreas, and heart) and then to alteration of the structure and function of these organs. The natural history of hereditary hemochromatosis includes three stages: latency, biologic expression (appearing rarely before the age of 20 years and corresponding to increased iron parameters, such as serum iron, transferrin saturation, and serum ferritin), and clinical expression. The first clinical symptoms appear generally at about age 40 years in males and later in females, approximately age 50 years, because of the protective effects of menstrual blood loss and of pregnancies. These clinical symptoms are nonspecific and include fatigue, skin pigmentation, hepatomegaly, arthritis, diabetes, and cardiomyopathy (1, 2) .
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Hereditary hemochromatosis is one of the sole genetic diseases benefiting from simple and efficient treatment when implemented early. Treatment relies on regular therapeutic venesection, generally weekly, until iron depletion occurs (i.e., normalization of iron parameters) and is followed by a maintenance treatment. Without early implementation of such a treatment, the disease has a poor prognosis and therefore can evolve toward irreversible damage, such as hepatocellular carcinoma or heart failure (1-3).
In 1996, a candidate gene for hereditary hemochromatosis was cloned on chromosome 6, at position 6p21. 3 (4) . This gene, HFE, encodes the HFE protein, which is a transmembrane glycoprotein implied in modulation of iron uptake (4, 5) . The gene contains a main mutation, C282Y, corresponding to substitution of a tyrosine for a cysteine at amino acid 282 and preventing formation of a disulfide bond (4, 6) . This mutation, whose allelic frequency varies between 0.5 and 10 percent in Caucasian populations (7, 8) , is present in a homozygous state in 80-95 percent of patients from northern Europe (4, 7, (9) (10) (11) . In some US populations, only 60 percent of hemochromatosis patients are homozygous for this mutation (12) . Besides this C282Y mutation, two other susceptibility factors associated with milder forms of hereditary hemochromatosis (H63D, S65C) and about 10 rare mutations have been identified in the HFE gene (9, (13) (14) (15) (16) .
Discovery of the HFE gene has enabled a better understanding of the physiopathologic mechanisms implied in hereditary hemochromatosis. However, this pathology remains complex and presents a large phenotypic heterogeneity (17) (18) (19) . The different mutations identified in the HFE gene do not have the same penetrance, and rapidity of the evolution of iron overload can be modified by factors that may reduce the iron stores (blood donation) or increase them (intake of iron). Moreover, the severity of the disease can vary in patients with similar degrees of iron overload. For example, the risk of cirrhosis is increased by excessive alcohol consumption or the presence of viral hepatitis (20) , while the risk of cardiomyopathy is increased by high intake of vitamin C, which potentiates iron uptake. Phenotypic expression of hereditary hemochromatosis can therefore be influenced by environmental factors and is the result of interactions between the gene and modifying factors.
The aim of the present study was to identify the influence of excessive alcohol consumption on expression of the disease in patients homozygous for the main mutation (C282Y). To do so, we analyzed a cohort of 378 hemochromatosis subjects treated in a blood center of western Brittany, France, where the frequency of the disease is particularly high (21) . This study showed that excessive alcohol consumption significantly increases the phenotypic expression of hereditary hemochromatosis.
MATERIALS AND METHODS

Study population
Brittany is a region of approximately 3 million inhabitants located in the western part of France. Its population is relatively ethnically homogeneous; most of the inhabitants are of Celtic origin. This study included 378 C282Y-homozygous hemochromatosis patients treated in a blood center of western Brittany whose transferrin saturation concentration was greater than or equal to 45 percent and for whom the questionnaire item on alcohol consumption was documented correctly.
Clinical questionnaire
At a patient's first visit to the blood center, a physician specialist completed a clinical questionnaire. It contained information on sociodemographic characteristics of the patient (e.g., gender, age, age at disease onset, circumstances of disease diagnosis, lifestyle factors, height, weight), clinical signs (fatigue, skin pigmentation, hepatomegaly, arthritis, cardiomyopathy, metabolic disorders (i.e., diabetes, hypercholesterolemia, hypertriglyceridemia)), and biochemical parameters (serum ferritin, serum iron, transferrin saturation, alanine aminotransferase (ALT), aspartate aminotransferase (AST)). Also available were data on the treatment of patients, such as number and quantity of venesections and quantity of iron removed. This questionnaire also included a detailed item on daily consumption of alcohol, measured by the number of glasses of alcohol drunk each day (including wine, beer, and liquors). These data enabled the quantity of ethanol (in grams) consumed each day, by each patient in the cohort, to be determined. Excessive alcohol consumption was defined as daily consumption of more than or equal to 60 g. Very moderate alcohol consumption was defined as less than 20 g of ethanol per day.
Measurement of iron parameters and determination of HFE genotype
Serum iron concentrations were measured by using standard biochemical methods. The normal range of serum ferritin for women was 15-200 µg/liter and for men was 30-300 µg/liter. The normal range of transferrin saturation was 20-45 percent. DNA samples harboring the C282Y mutation were identified by polymerase chain reaction and restriction enzyme assays, as described previously (13, 21) , and, more recently, by denaturing high-performance liquid chromatography (22) .
Statistical analysis
In this paper, quantitative variables are expressed as mean (standard deviation). Differences in means between groups were tested by using Student's t test or the Mann-Whitney U test. Qualitative values are presented as percentages and were compared by using the chi-square test or Fisher's exact test in case of sample size samples. Because the distribution of the serum ferritin variable was highly skewed, logarithmic transformation was performed to normalize the measures for all statistical analyses. A p value of less than 5 percent was considered significant. Statistical analyses were conducted by using Epi-Info software (version 6.04; Centers for Disease Control and Prevention, Atlanta, Georgia).
The biochemical and clinical characteristics of the whole cohort were described. Then, the biologic characteristics of patients according to their alcohol consumption (≥60 vs. <60 g/day) were compared. The influence of this factor on disease expression, measured by levels of serum ferritin, serum iron, and transferrin saturation, was assessed by using a linear regression analysis. In a first step, we conducted a univariate analysis and then a multivariate analysis with adjustment for potential confounding factors such as gender and age. Moreover, the frequency of clinical signs observed in patients reporting excessive alcohol consumption was compared with that observed in patients reporting lower alcohol consumption. Odds ratios with 95 percent confidence intervals were calculated.
This study fulfilled the bioethical rules in place in France. Informed consent was obtained from patients before blood samples were taken.
RESULTS
Study population
This cohort included 378 subjects, of whom 60.3 percent were male (sex ratio: 1.5). The age of patients ranged from 18 to 80 years. Age at onset tended to be higher in females than in males (48.8 vs. 46.5 years, p = 0.053). The diagnosis was made mainly on the basis of clinical features (57.4 percent), less frequently through family testing (30.7 percent) or during an occupational medicine visit (9.5 percent). Of those patients, 8.7 percent reported excessive alcohol consumption (≥60 g/day, n = 33). The C282Y/C282Y genotype was associated with a severe form of the disease, characterized by elevated iron parameters, especially in males (table 1) . The most frequent clinical signs observed in those subjects at time of onset were fatigue (60. 
Characteristics of patients according to alcohol consumption
Frequency of excessive alcohol consumption. In this cohort, 14.8 percent of the hereditary hemochromatosis patients declared that they were nondrinkers, 50.3 percent that they consumed alcohol occasionally, and 34.9 percent that they consumed alcohol regularly. In all, 8.7 percent of the hereditary hemochromatosis patients in this cohort reported excessive alcohol consumption (n = 33). This group included mainly males (n = 31): 13.6 percent of them estimated their alcohol consumption to be equal to or greater than 60 g per day (31/228) compared with only 1.3 percent of females (2/150) (p < 0.0001). Mean number of glasses of alcohol consumed each day was significantly higher for males than for females (2.2 vs. 0.4; p < 10 -6 ), the overall range being 0-13 glasses per day. Mean age at onset was not significantly lower in men reporting excessive alcohol consumption compared with those consuming smaller quantities (45.8 vs. 46.6 years, p = 0.71). For women, this analysis was difficult because the number of women in the "excessive" group was low (n = 2). Table 2 also reports the results of the linear regression analyzing the relation between alcohol consumption and iron overload, measured by the logarithm of serum ferritin, serum iron, and transferrin saturation. These results remained unchanged after adjustment for gender and age. Moreover, ALT and AST levels were also significantly higher in subjects reporting heavy alcohol consumption ( Clinical signs according to alcohol consumption. The frequency of major clinical signs of hereditary hemochromatosis observed in patients declaring excessive alcohol consumption compared with signs observed in patients reporting lower alcohol consumption is shown in figure 2 . Patients who drank more than 60 g of alcohol per day had a significantly increased risk of skin pigmentation (51.5 vs. 
DISCUSSION
The present study highlights the phenotypic expression of hereditary hemochromatosis in patients homozygous for the main mutation of the HFE gene (C282Y) and provides precise quantitative data about the impact of alcohol consumption on expression of the disease in those patients. This study shows that excessive alcohol consumption increases the severity of the disease in C282Y-homozygous patients, resulting in higher iron parameters and more frequent clinical signs. Alcohol consumption associated with a genetic factor increases expression of the disease and therefore the risk of cirrhosis and cancer. Excessive alcohol consumption is thus an aggravating factor. In our study, the prevalence of excessive alcohol consumption among hereditary hemochromatosis patients (8.7 percent) was lower than that reported in previous studies, which were performed before the HFE gene was discovered and which should therefore have included, as hereditary hemochromatosis patients, subjects who had alcoholic siderosis (23, 24) . For example, in a study performed in 1992, Loreal et al. (23) showed that in their cohort of 127 patients, 29 percent were alcoholic. Before the genetic test existed, the distinction between patients affected with hereditary hemochromatosis and those affected with alcoholic siderosis was difficult to establish. Therefore, most studies should have considered some patients with alcoholic siderosis as having hereditary hemochromatosis. Discovery of the HFE gene in 1996 has provided a complementary element for helping to set the diagnosis of hereditary hemochromatosis. Our study measured the effect of alcohol consumption in hereditary hemochromatosis patients whose diagnosis was not ambiguous and who were homozygous for the main mutation of the HFE gene. In 1995, Adams and Agnew (25) showed similar results. They focused their study on diagnosis criteria based on the presence of a humanlymphocyte-antigen identical sibling with iron overload. Heavy alcohol consumption (>80 g/day) was observed in 15 percent of their hemochromatosis patients (25) .
Note that declaration of alcohol consumption is subjective (26, 27) and that consumption must certainly be, at least in some cases, underestimated. However, this issue is addressed in all studies dealing with alcohol consumption and should not have affected our study more than others.
In this study, we showed that excessive alcohol consumption increased the severity of the disease, characterized by more frequent clinical signs, notably skin pigmentation, diabetes, and hepatomegaly. It is known that alcohol worsens the hepatic damage produced by iron in hereditary hemochromatosis. Several studies reported that excessive alcohol consumption greatly increased the prevalence of hepatic fibrosis and cirrhosis in hereditary hemochromatosis patients (23, 28) . For example, in a recent study, Fletcher et al. (28) quantified the contribution of excessive alcohol consumption to the development of cirrhosis in a cohort of 224 C282Y-homozygous hemochromatosis subjects. These authors clearly observed that patients who reported excessive alcohol consumption (>60 g per day) seemed nine times more likely to develop cirrhosis compared with subjects who drank less than this quantity. The frequency of cirrhosis reached 61.1 percent in the group of heavy drinkers, whereas it was uncommon in the other group of patients (7.1 percent). Moreover, the authors showed that patients reporting heavy alcohol consumption were more likely to develop cirrhosis at an earlier age. Indeed, the mean age of patients who consumed excessive quantities of alcohol was 46.5 years (standard deviation, 10.5) compared with 53.7 years (standard deviation, 11.9) in patients who drank less than 60 g of alcohol per day. Fletcher et al. also reported that the findings were not significantly modified by considering a threshold, for alcohol consumption, of 40 g per day.
In our study, the influence of alcohol consumption on the risk of extensive liver fibrosis or cirrhosis could not be estimated. A liver biopsy was performed for the majority of the patients, but the population sample was not sufficient to enable us to draw conclusions.
Iron overload itself can result in hepatic fibrosis and cirrhosis. However, in hemochromatosis patients, this overload should be influenced by cofactors such as hepatitis or alcohol (20, (23) (24) (25) . According to Adams and Agnew, "patients with heavy alcohol consumption had a higher prevalence of cirrhosis at the time of diagnosis without a significant increase in iron overload, suggesting an additive hepatotoxic effect of the alcohol rather than any secondary effects on iron absorption or metabolism" (25, p. 726). Chronic alcohol consumption therefore has an additive hepatotoxic effect. In a recent editorial, Britton and Bacon (29) explained the possible mechanisms by which the combination of alcohol and iron overload lead to hepatic fibrogenesis. This occurrence may be the result of two phenomena: first, both iron overload and alcohol induce oxidative stress in the liver, causing oxidative injury and fibrogenesis; second, these two factors may also produce hepatocellular damage by nonoxidative mechanisms (29) .
Our findings have implications for the public health field in terms of the adoption of preventive strategies. Alcohol consumption associated with genetic factors increases the severity of hereditary hemochromatosis and therefore the risk of cirrhosis and cancer. Consequently, patients who have the disease should be discouraged from consuming excessive quantities of alcohol because of the added hepatotoxicity it induces. In any case, treatment by regular venesection is recommended to reduce iron stores to normal values and to decrease the risk that the disease will progress, causing irreversible damage (28, 29) .
In conclusion, phenotypic expression of hereditary hemochromatosis is influenced by exogenous risk factors such as alcohol consumption, as illustrated in this study. The severity of the disease is the result of interactions between genetic and environmental factors. Therefore, the pathology of hereditary hemochromatosis is multifactorial and, with this disease, it is interesting to analyze the complexity of gene-gene and gene-environment interactions (19) .
